Andlauer Healthcare Group Inc. (TSX: AND)

Andlauer Healthcare Group Income Statement

Financials in millions CAD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	647.95	648.42	440.12	314.34	289.99
Revenue Growth (YoY)	-0.07%	47.33%	40.01%	8.40%	4.69%
Cost of Revenue	500.47	489.58	329.36	234.79	221.9
Gross Profit	147.48	158.85	110.75	79.55	68.09
Selling, General & Admin	51.43	48.5	37.05	28.61	23.09
Other Operating Expenses	-0.41	-0.33	0.37	-0.05	-0.15
Operating Expenses	51.43	48.5	37.05	28.61	23.09
Operating Income	96.05	110.35	73.7	50.94	44.99
Interest Income	3.17	0.6	0.2	0.29	1
Interest Expense	8.21	6.86	6.22	4.6	3.5
Other Expense / Income	0.41	0.33	-40.76	0.05	0.72
Pretax Income	90.61	103.76	108.44	46.58	42.35
Income Tax	24.47	27.48	18.49	8.87	12
Net Income	66.14	76.28	89.95	37.71	29.77
Net Income Growth	-13.29%	-15.21%	138.52%	26.67%	11.41%
Shares Outstanding (Basic)	42	42	39	38	38
Shares Outstanding (Diluted)	43	43	40	38	38
Shares Change	-0.30%	6.70%	3.94%	1.87%	4.62%
EPS (Basic)	1.58	1.82	2.30	1.00	0.79
EPS (Diluted)	1.55	1.79	2.25	0.98	0.79
EPS Growth	-13.41%	-20.44%	129.59%	24.05%	6.76%
Free Cash Flow	78.83	109.17	74.42	45.56	54.84
Free Cash Flow Per Share	1.85	2.56	1.86	1.18	1.45
Gross Margin	22.76%	24.50%	25.16%	25.31%	23.48%
Operating Margin	14.82%	17.02%	16.75%	16.21%	15.52%
Profit Margin	10.21%	11.76%	20.44%	12.00%	10.27%
Free Cash Flow Margin	12.17%	16.84%	16.91%	14.50%	18.91%
Effective Tax Rate	27.00%	26.49%	17.05%	19.03%	28.35%
EBITDA	164.2	175.07	119.45	79.2	71.56
EBITDA Margin	25.34%	27.00%	27.14%	25.19%	24.68%
Depreciation & Amortization	68.15	64.45	42.72	28.02	25.71
EBIT	96.05	110.62	76.74	51.18	45.85
EBIT Margin	14.82%	17.06%	17.44%	16.28%	15.81%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.